Yuhan Corporation
000100
Classifica tra le azioni
#3833
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Prezzo delle azioni
$63.22
Capitalizzazione di mercato
$4.27B
Variazione (1 giorno)
-3.12%
Variazione (1 anno)
-23.57%
Paese
KR
Scambia Yuhan Corporation (000100)
Categoria
Healthcare
Margine operativo per Yuhan Corporation (000100)
Margine operativo al October 2026 TTM: 5.46%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Yuhan Corporation, il margine operativo attuale (TTM) è 5.46%. Alla fine del 2024, il margine operativo era 2.65%.
Storico del margine operativo per Yuhan Corporation da 2007 a 2026
Margine operativo alla fine di ogni anno
| Anno | Margine Operativo | Cambia |
|---|---|---|
| 2026 (TTM) | 5.46% | -3.36% |
| 2025 | 5.65% | 113.21% |
| 2024 | 2.65% | -33.92% |
| 2023 | 4.01% | 97.54% |
| 2022 | 2.03% | -29.51% |
| 2021 | 2.88% | -44.62% |
| 2020 | 5.20% | 19.82% |
| 2019 | 4.34% | 31.52% |
| 2018 | 3.30% | -45.63% |
| 2017 | 6.07% | -17.97% |
| 2016 | 7.40% | -2.63% |
| 2015 | 7.60% | 3.97% |
| 2014 | 7.31% | 11.60% |
| 2013 | 6.55% | 46.86% |
| 2012 | 4.46% | -38.23% |
| 2011 | 7.22% | -42.01% |
| 2010 | 12.45% | -6.74% |
| 2009 | 13.35% | -1.69% |
| 2008 | 13.58% | -6.47% |
| 2007 | 14.52% | 0.00% |
Margine operativo per aziende simili o concorrenti
| Azienda | Margine Operativo | Differenza del margine operativo | Il paese |
|---|---|---|---|
| 19.41% | -96.45% |
DE
|
|
| 19.68% | -96.40% |
DE
|
|
| 10.52% | -98.07% |
JP
|
|
| 17.08% | -96.87% |
CH
|
|
| 22.93% | -95.80% |
IN
|
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.